HOMCOS:

#WARNING:no index is registered index "YP_009725297.1" in "https://rest.uniprot.org/uniprotkb/" url "https://rest.uniprot.org/uniprotkb/YP_009725297.1.txt".
Please visit the UniProt website(https://www.uniprot.org), and get a proper ID/AC for your query protein.

		Contact Molecules for Homologous Proteins
[Summary Bars]	[Full Bars]	Site Table[0.0 %]	[Back to Search Page]	[Back to HOMCOS]
[Sites by Variants]	[SupCon3D]	[help]	seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100]	[show] [download] [help]

PID	QueryLength	Homolgous Sequence in PDB	UniProt Query	TITLE
25151	180	29	YP_009725297.1()
QUERYSEQ	MESLVPGFNEKTHVQLSLPVLQVRDVLVRGFGDSVEEVLSEARQHLKDGTCGLVEVEKGVLPQLEQPYVFIKRSDARTAPHGHVMVELVAELEGIQYGRSGETLGVLVPHVGEIPVAYRKVLLRKNGNKGAGGHSYGADLKSFDLGDELG TDPYEDFQENWNTKHSSGVTRELMRELNGG

[BLAST file for PDB] (plain) (bar) (multiple alignment) [BLAST for UniProt: (plain) (bar) (multiple alignment) (PSSM file) ]

  [n]:site number of query sequence.  [a]:amino acid of query sequence.  [s]:predicted secondary structure.
  [e]:predicted exposed/buried.  [acc]:predicted relative accesssibility(%).  [pdb]:PDB code of homologous structure.
  [contact_mols]:predicted binding molecules  [observed aa]:Observed amino acids among homologous sequences.  [feature table]:UniProt Feature Table
  [variant]:UniProt Human Variant.

n	a	s	e	acc	pdb	contact_mols	observed aa	feature table	variant
1	M	B	e	50.2	8aou_A		M	DISORDER predicted by DISOPRED
2	E	T	e	50.8	8aou_A		E	DISORDER predicted by DISOPRED
3	S	T	e	73.4	8aou_A		S	DISORDER predicted by DISOPRED
4	L	B	e	47.2	8aou_A		L	DISORDER predicted by DISOPRED
5	V		b	11.3	8aou_A		VA
6	P	T	e	72.1	8aou_A		LP
7	G	T	e	71.4	8aou_A		G
8	F		e	22.0	8aou_A		VFI
9	N		e	53.3	8aou_A		NS
10	E	T	e	58.8	8aou_A	compound 92G OF6	E
11	K	T	e	55.2	8aou_A	nucleotide	K
12	T	T	e	22.7	8aou_A	nucleotide	T
13	H	E	b	5.8	8aou_A		H
14	V	E	e	22.7	8aou_A	compound QO6 92G NT9 OF6	V
15	Q	E	e	39.8	8aou_A		Q
16	L	E	b	7.9	8aou_A	compound 92G NT9 OF6	L
17	S	E	e	66.4	8aou_A		S
18	L	E	b	1.1	8aou_A		L
19	P	E	b	11.6	8aou_A		P
20	V	E	b	0.7	8aou_A		V
21	L		b	0.0	8aou_A		L
22	Q		e	24.0	8aou_A		Q
23	V	T	b	0.0	8aou_A		V
24	R	T	e	82.6	8aou_A		R
25	D	T	e	35.2	8aou_A		D
26	V		b	1.3	8aou_A		V
27	L	S	e	56.2	8aou_A	hetero DPOLA_HUMAN	L
28	V	S	e	77.3	8aou_A	hetero DPOLA_HUMAN	V
29	R		e	37.2	8aou_A		R
30	G		b	10.7	8aou_A	hetero DPOLA_HUMAN	G
31	F	S	b	9.6	8aou_A	hetero DPOLA_HUMAN	F
32	G		e	21.4	8aou_A	hetero DPOLA_HUMAN	G
33	D	S	e	61.7	8aou_A	hetero DPOLA_HUMAN	D
34	S	S	b	1.6	8aou_A		S
35	V	H	b	0.0	8aou_A		V
36	E	H	b	13.1	8aou_A		E
37	E	H	e	27.1	8aou_A		E
38	V	H	b	0.0	8aou_A		AV
39	L	H	b	0.0	8aou_A		L
40	S	H	b	5.5	8aou_A		SA
41	E	H	e	27.6	8aou_A	compound OEI	E
42	A	H	b	0.0	8aou_A		A
43	R	H	b	0.0	8aou_A	compound QO6 92G NT9 OF6	R
44	Q	H	e	24.5	8aou_A	hetero DPOLA_HUMAN	EQ
45	H	H	e	23.0	8aou_A	hetero DPOLA_HUMAN compound OEI OG3	H
46	L	H	b	0.6	8aou_A	compound QO6 92G NT9 OF6	L
47	K	H	e	42.9	8aou_A	compound QO6 92G NT9 OF6	K
48	D	H	e	75.3	8aou_A	hetero DPOLA_HUMAN	NDS
49	G	T	e	33.3	8aou_A		G
50	T		e	52.6	8aou_A	hetero DPOLA_HUMAN	T
51	C	E	b	0.0	8aou_A		C
52	G	E	b	0.0	8aou_A		G
53	L	E	b	0.0	8aou_A		LI
54	V	E	b	0.7	8aou_A		V
55	E		b	19.1	8aou_A		E
56	V	S	e	40.0	8aou_A		LV
57	E		e	33.7	8aou_A		E
58	K	S	e	63.7	8aou_A		K
59	G	T	e	31.0	8aou_A		G
60	V	T	b	0.0	8aou_A		V
61	L	G	b	17.4	8aou_A		L
62	P	G	e	79.8	8aou_A		P
63	Q	G	e	43.4	8aou_A		Q
64	L	S	b	5.1	8aou_A		LP
65	E		e	57.3	8aou_A	hetero DPOLA_HUMAN	E
66	Q	S	e	40.8	8aou_A		Q
67	P	S	b	0.0	8aou_A		P
68	Y	E	b	8.3	8aou_A		Y
69	V	E	b	0.0	8aou_A		V
70	F	E	b	1.0	8aou_A		F
71	I	E	b	0.0	8aou_A		I
72	K	E	b	0.0	8aou_A		K
73	R	E	e	24.9	8aou_A		R
74	S	S	b	18.8	8aou_A	nucleotide	S
75	D	S	e	21.6	8aou_A	nucleotide	D
76	A	S	e	56.2	8aou_A		A
77	R	S	e	60.1	8aou_A	nucleotide	QRL
78	T		b	3.9	8aou_A		GTS
79	A		b	16.1	8aou_A	nucleotide	TA
80	P		b	7.8	8aou_A		NPD
81	H	S	e	105.2	8aou_A		H
82	G	S	e	47.6	8aou_A		G
83	H	E	e	30.4	8aou_A		HY
84	V	E	b	13.3	8aou_A		KVR
85	M	E	b	0.0	8aou_A	nucleotide	VM
86	V	E	b	0.0	8aou_A		VR
87	E	E	b	4.5	8aou_A		E
88	L	E	b	0.0	8aou_A		L
89	V	E	b	0.0	8aou_A		V
90	A	E	b	0.0	8aou_A		A
91	E	E	b	2.5	8aou_A	hetero RS30_HUMAN	E
92	L	S	b	1.7	8aou_A		LM
93	E	S	e	59.8	8aou_A		DE
94	G		e	32.1	8aou_A	hetero RS30_HUMAN	G
95	I		e	55.6	8aou_A	hetero RS30_HUMAN	IV
96	Q		e	20.4	8aou_A	hetero RS30_HUMAN	Q
97	Y	S	b	1.7	8aou_A	hetero RS30_HUMAN	Y
98	G		e	22.6	8aou_A		G
99	R		e	43.5	8aou_A	hetero RS30_HUMAN A0A4W2DI10_BOBOX nucleotide	R
100	S		e	32.8	8aou_A	nucleotide	S
101	G	S	e	21.4	8aou_A	nucleotide	G
102	E		e	62.3	8aou_A		IET
103	T	E	b	11.0	8aou_A		T
104	L	E	b	15.7	8aou_A		L
105	G	E	b	0.0	8aou_A		G
106	V	E	b	0.0	8aou_A		V
107	L	E	b	0.0	8aou_A		L
108	V	E	b	0.0	8aou_A		V
109	P	E	b	7.0	8aou_A	hetero DPOLA_HUMAN compound OEI OG3	P
110	H		e	26.7	8aou_A		H
111	V	S	e	81.3	8aou_A	hetero DPOLA_HUMAN compound OEI OG3	V
112	G	S	e	28.6	8aou_A	hetero DPOLA_HUMAN	G
113	E		b	9.0	8aou_A		E
114	I		e	104.1	8aou_A		TI
115	P		b	19.4	8aou_A		P
116	V	S	e	52.0	8aou_A		VI
117	A	E	e	25.9	8aou_A		A
118	Y	E	e	62.2	8aou_A		Y
119	R	E	e	38.7	8aou_A		R
120	K	E	e	41.5	8aou_A		NK
121	V	E	b	0.0	8aou_A		V
122	L	E	b	0.0	8aou_A		L
123	L	E	b	0.0	8aou_A	compound QO6 92G NT9 OF6	L
124	R	E	e	27.3	8aou_A	nucleotide	R
125	K	S	b	12.7	8aou_A	nucleotide compound QO6 92G NT9 OF6	K
126	N	S	e	38.8	8aou_A	nucleotide	N
127	G	S	e	42.9	8aou_A		G
128	N		b	18.8	8aou_A	nucleotide	N
129	K		b	9.0	8aou_A		K
130	G		b	11.9	8aou_A		G
131	A	S	b	2.7	8aou_A		A
132	G	S	b	3.6	8aou_A		G
133	G		e	21.4	8aou_A		G
134	H	T	e	59.2	8aou_A		H
135	S	T	e	64.8	8aou_A		S
136	Y	T	e	50.0	8aou_A	nucleotide	YF
137	G	T	b	11.9	8aou_A		G
138	A	T	e	77.7	8aou_A		IA
139	D	T	e	69.8	8aou_A		D
140	L	T	e	41.0	8aou_A	nucleotide	L
141	K		e	67.0	8aou_A		K
142	S		e	25.0	8aou_A	nucleotide	S
143	F		e	43.1	8aou_A		YF
144	D		e	53.7	8aou_A		D
145	L		e	29.2	8aou_A	hetero RS3_HUMAN	L
146	G		e	25.0	8aou_A	hetero RS3_HUMAN	G
147	D		e	22.8	8aou_A	hetero G1TNM3_RABIT RS3_HUMAN	DV
148	E	B	b	0.0	8aou_A	hetero RS3_HUMAN G1TNM3_RABIT	E
149	L	T	b	8.4	8aou_A	hetero RS3_HUMAN G1TNM3_RABIT	L
150	G	T	b	3.6	8aou_A	hetero RS3_HUMAN G1TNM3_RABIT	G
151	T	B	b	6.5	8aou_A	hetero RS3_HUMAN RS30_HUMAN G1TNM3_RABIT	T
152	D		b	12.3	8aou_A	hetero RS3_HUMAN G1TNM3_RABIT	D
153	P	T	e	48.8	8aou_A	hetero RS3_HUMAN G1TNM3_RABIT G1T8A2_RABIT	P
154	Y	T	e	64.8	8aou_A	hetero RS3_HUMAN RS2_HUMAN	IY
155	E	T	e	58.3	8aou_A	hetero RS3_HUMAN G1TNM3_RABIT	E
156	D	T	e	95.1	8aou_A	hetero RS3_HUMAN nucleotide	D
157	F		e	47.8	8aou_A	hetero RS2_HUMAN	YF
158	Q		e	87.2	8aou_A	hetero RS2_HUMAN RS3_HUMAN G1TNM3_RABIT	EQ
159	E		b	6.5	8aou_A	hetero RS3_HUMAN G1TNM3_RABIT	QE
160	N		e	50.9	8aou_A	hetero RS3_HUMAN nucleotide	N
161	W		b	0.0	8aou_A	hetero RS2_HUMAN	W
162	N	T	e	23.6	8aou_A	hetero RS2_HUMAN nucleotide	N
163	T	T	e	95.5	8aou_A	hetero RS3_HUMAN	T
164	K		b	11.3	8aou_A	nucleotide	K
165	H		e	79.1	8aou_A	hetero RS3_HUMAN nucleotide	H
166	S		b	17.2	8aou_A		GS
167	S	S	e	71.1	8aou_A	nucleotide	SG
168	G	T	e	82.1	8aou_A	nucleotide metal UNX	G
169	V	T	e	41.3	8aou_A	nucleotide	VA
170	T		e	63.0	8aou_A	hetero RS2_HUMAN	LT
171	R		e	104.7	8aou_A	nucleotide metal MG	R
172	E	S	e	76.4	8aou_A	nucleotide	E
173	L		e	64.6	8aou_A	hetero RS2_HUMAN	L
174	M		e	22.2	8aou_A	hetero RS2_HUMAN	TMI
175	R	S	e	47.4	8aou_A	hetero RS30_HUMAN G1T8A2_RABIT nucleotide	R
176	E	S	e	31.7	8aou_A	hetero RS30_HUMAN G1T8A2_RABIT	E
177	L	S	e	21.9	8aou_A	hetero RS2_HUMAN	L
178	N	S	e	40.6	8aou_A	hetero RS2_HUMAN	N
179	G		e	45.2	8aou_A	hetero RS30_HUMAN G1T8A2_RABIT	G
180	G		e	102.4	8aou_A	hetero RS30_HUMAN G1T8A2_RABIT	G	DISORDER predicted by DISOPRED

Contact Molecules for Homologous Proteins

Site Table[0.0 %]